676136-36-0

Basic information

• Product Name: ba-Alanine, N-(4-ethylphenyl)-, ethyl ester (9CI)
• Synonyms: bta-Alanine,N-(4-ethylphenyl)-,ethylester(9CI);ba-Alanine, N-(4-ethylphenyl)-, ethyl ester (9CI)
• CAS NO: 676136-36-0
• Molecular Formula: C₁₃H₁₉NO₂
• Molecular Weight: 221.29546
• Product Categories: ETHYL
• Mol File: 676136-36-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ba-Alanine, N-(4-ethylphenyl)-, ethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: ba-Alanine, N-(4-ethylphenyl)-, ethyl ester (9CI)(676136-36-0)
• EPA Substance Registry System: ba-Alanine, N-(4-ethylphenyl)-, ethyl ester (9CI)(676136-36-0)

Safety Data

• Hazardous Substances Data: 676136-36-0(Hazardous Substances Data)

Upstream product

• 140-88-5 ethyl acrylate 
• 589-16-2 4-aminoethylbenzene 

Downstream Products

• 263896-27-1 6-ethyl-2,3-dihydro-1H-quinolin-4-one 

Relevant articles and documents

Aza-Michael mono-addition using acidic alumina under solventless conditions

Aza-Michael reactions between primary aliphatic and aromatic amines and various Michael acceptors have been performed under environmentally-friendly solventless conditions using acidic alumina as a heterogeneous catalyst to selectively obtain the corresponding mono-adducts in high yields. Ethyl acrylate was the main acceptor used, although others such as acrylonitrile, methyl acrylate and acrylamide were also utilized successfully. Bi-functional amines also gave the mono-adducts in good to excellent yields. Such compounds can serve as intermediates for the synthesis of anti-cancer and antibiotic drugs.

Titania nanoparticles stabilized HPA in SBA-15 for the intermolecular hydroamination of activated olefins

A liquid phase hydroamination (HA) of α,β-ethylenic compounds with amines was investigated with TiO2 nanoparticles stabilized 12-tungstophosphoric acid (TPA) in SBA-15. The catalysts were prepared by wet impregnation of TPA/TiO2 nanoparticles into the SBA-15 and calcined at different temperatures. The characterization results reveal that the textural properties and the acidity of the prepared catalysts can be finely controlled with the simple adjustment of the calcination temperature and the structure of the support, decorated with the TiO2 and TPA nanoparticles, was intact even after the modification. The prepared catalysts were investigated for HA of ethyl acrylate with different aromatic and aliphatic amines over a wide range of reaction conditions to optimize the yield and the selectivity of product. It was found that this process is 100% atom efficient and the catalytic performance depended significantly on the loading of TPA over the catalyst and the calcination temperature. Under optimized reaction conditions, the best catalyst, 15 wt%TPA/22.4 wt%TiO2/SBA-15 calcined at 1123 K, offered the highest conversion of p-ethylaniline (70%) with 100% chemo-selectivity to the anti-Markovnikov product, i.e., the mono-addition product. The reaction was heterogeneously catalyzed and no contribution from leached TPA into the reaction was observed.

METHODS OF TREATMENT OF AMYLOIDOSIS USING BI-CYCLIC ASPARTYL PROTEASE INHIBITORS

The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.

2-AMINO- AND 2-THIO-SUBSTITUTED 1,3-DIAMINOPROPANES

Disclosed are compounds of the formula: where variables Q, Z, X, R15, R2, R3, and Rc are defined herein. Compounds disclosed herein are inhibitors of the beta-secretase enzyme and are therefore useful in the treatment of Alzheimer’s disease and other diseases characterized by deposition of A beta peptide in a mammal.